Because we showed that TGF-β is a central regulator of the upregulated genes of our signature and also found that the migratory cells have active TGF-β signaling during invasion in the primary tumor in vivo, this raises the question that our signature may have some overlap with EMT or TIC gene-expression profiles. Here, TGFB1 is linked to neoplasm.